MannKind’s INHALE-1 Study: Pediatric Diabetes Breakthrough
MannKind completes enrollment for the INHALE-1 study, evaluating the efficacy of inhaled insulin Afrezza for pediatric diabetes treatment. Positive trial ...
- Latest
- Trending
MannKind completes enrollment for the INHALE-1 study, evaluating the efficacy of inhaled insulin Afrezza for pediatric diabetes treatment. Positive trial ...
Ethereum co-founder Jeffrey Wilcke executes significant Ether transactions, indicating a strategic financial strategy. Despite the transactions, Ethereum's market remains stable, ...
The $PROM token has experienced an unprecedented 78% surge after a personal investment by DWFLab's Andrei Grachev. This highlights growing ...
The Baby Doge Coin $BABYDOGE airdrop is generating excitement in the crypto community, offering monetary rewards and governance tokens. Participating ...
Bitcoin's price surge to $52k triggers massive short squeeze, wiping out over $180m worth of short positions. It also pushes ...
The Australian stock market, S&P/ASX 200, gained 0.77% fueled by technology and healthcare sectors. Altium Ltd reached a new high, ...
Ethereum's price rally continues as it surpasses $2,800, fueled by factors like DeFi activity, Ethereum 2.0 anticipation, institutional adoption, NFT ...
Chai AI is revolutionizing conversational AI with its expansive user base and developer-centric platform, setting new benchmarks for user engagement. ...
Dogwifhat, a meme-based digital asset on the Solana blockchain, has surged 23.2% in value, becoming a top memecoin contender. Its ...
The Ethereum Name Service (ENS) has launched an airdrop initiative, offering free tokens and governance tokens to its community members. ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.